Nektar Therapeutics Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (35)

Latest Posts

About This Stock More About This Stock
Nektar Therapeutics Downgraded To Sell From Buy At Goldman Sachs
Article By: The Fly
Tuesday, October 8, 2019 9:15 AM EDT
Goldman Sachs analyst Paul Choi double downgraded Nektar Therapeutics to Sell from Buy with a price target of $16, down from $54.
In this article: NKTR
Read
Nektar (NKTR) Leaves The S&P 500
Article By: Bespoke Investment Group
Friday, September 27, 2019 10:47 AM EDT
By the time NKTR officially became a member of the S&P 500, the stock had peaked out at $108.44 only eleven days earlier. Since then, the stock has dropped over 83%.
In this article: NKTR
Read
Nektar Therapeutics Falls Victim To The Index Curse
Article By: Bespoke Investment Group
Friday, August 9, 2019 1:48 PM EDT
The last year and a half has been tough for NKTR, what’s even worse is that all of the problems for the stock started to happen right when it was added to the S&P 500 in March 2018.
In this article: NKTR Also: AZN, BMY, PFE
Read
These Are The Three Things Goldman's Clients Are Most Worried About
Article By: Tyler Durden
Sunday, December 9, 2018 4:43 PM EDT
Goldman's chief equity strategist David Kostin writes that the bank's clients remain nervous with concerns rising over three key market themes: US-China trade relations, the pace of Fed tightening, and concerns about recession.
In this article: FLR, KORS, NFX, PWR, SLB, NKTR, NWSA, VIX, HAL
Read
5 Best Biotech Stocks To Buy In October
Article By: Zacks Investment Research
Monday, October 1, 2018 11:50 AM EDT
Here are five stocks that are expected to move north following successful drug developments.
In this article: CSBR, CYDY, INFI, NKTR, ZTS Also: AMRN, ACAD, SRPT, GILD, AGN
Read

PARTNER HEADLINES

Latest Tweets for $NKTR

No tweets yet!

$NKTR

Biotech Deal Sparks Rally
Susan Miller 2/15/2018 2:03:08 AM

I've had my eye on $NKTR.

1 to 1 of 1 comments